EARNINGS: Origin Enterprises beats operating profit target
The following is a round-up of earnings reports by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Origin Enterprises PLC - Dublin-based agricultural products and services provider - Reports results for the year ended July 31. Revenue rises 0.4%, or 2.3% at constant exchange rates, to EUR2.12 billion from EUR2.11 billion. Pretax profit decreases 1.2% to EUR78.1 million from EUR79.0 million, but operating profit rises 1.8%, or 2.8% at CER, to EUR100.7 million, " supported by growth in Living Landscapes and Latin America, together with an increased contribution from associates and joint venture." Basic earnings per share fall 12% to 43.61 euro cents from 49.59 cents, while adjusted diluted EPS declines 1.3% to 53.51 cents from 54.21 cents, in line with the guidance range Origin reported in June. Origin proposes 14.15 cents final dividend, leaving the annual total unchanged at 17.30 cents. "Having exceeded the operating profit ambition established at our 2022 capital markets day, we look forward to outlining the next phase of Origin's development and establishing a new set of medium-term financial ambitions at our next capital markets day in London on [November 17]," CEO Sean Coyle says.
----------
Microlise Group PLC - Nottingham, England-based provider of transport technology solutions to fleet operators - Reports results for the first half of 2026. Pretax profit falls 27% year-on-year to £1.4 million from £1.9 million. Adjusted pretax profit falls 49% to £1.9 million from £3.6 million. Revenue decreases 10% to £39.5 million from £44.1 million, "reflecting lower [original equipment manufacturer] revenues and lower non-recurring hardware revenues and project timing," with recurring revenue up 1% to £29.9 million. Annual recurring revenue rises 4% to £60.8 million, with direct customer ARR up 12% to £47.1 million. Adjusted earnings before interest, tax, depreciation and amortisation fall 16% to £5.2 million from £6.2 million, with the margin down to 13.2% from 14.1%, which Microlise says "represents a significant recovery from the 5.2% margin delivered in [the second half of 2025]". Looking ahead, Microlise expresses confidence that it will deliver full-year revenue and adjusted Ebitda "in line with current market expectations". Cites market consensus of revenue between £82.1 million to £84.2 million, adjusted Ebitda between £10.0 million to £11.1 million and net cash between £10.6 million to £11.1 million.
----------
S-Ventures PLC - London-based company that invests in brands across the natural, wellness, and food-tech sectors - Reports no gross revenue for the first half of 2026, against £6.7 million the year before, and no net sales revenue, down from £5.2 million. Swings to pretax loss of £157,000 from £483,000 profit and Ebitda loss of £157,000 from profit of £1.9 million. "The first half of 2026 has marked an important period of transition for S-Ventures PLC as we establish ourselves as a focused investment company following the completion of the reverse takeover of our former operating subsidiaries into AIM-listed Tooru PLC," says Chief Executive Scott Livingston. "We retain a significant shareholding in Tooru PLC and are encouraged by the progress being made across its portfolio of consumer brands...we also made an investment in an innovative drone technology business, reflecting our intention to diversify our investment portfolio. Looking ahead, we intend to pursue further investment opportunities, particularly through convertible loan notes, which we believe can provide attractive potential returns alongside participation in the future growth of investee companies."
----------
Diaceutics PLC - Belfast, Northern Ireland-based diagnostic testing company - Reports revenue of £17.5 million for the first half of 2026, up 20% or 22% at CER from £14.6 million the year before. ARR jumps 79% to £29.4 million from £16.4 million, and net revenue retention gros to 149% from 118%. Adjusted earnings before interest, tax, depreciation and amortisation rise to £1.1 million from £57,000. But pretax loss widens to £4.0 million from £3.0 million. Order book increases 38% to £43.7 million, with £15.7 million contracted for delivery in the second half. Company swings to positive free cash flow of £724,000 from £2.4 million, has no debt, and cash balance is £8.1 million at year end, down from £10.4 million one year prior, but still "leaving the group fully funded to deliver its organic growth strategy." Diaceutics "remains confident in delivering against its 2026 expectations." Targets "at least £8.0 million of cash at the 2026 year end, in line with analyst consensus".
----------
Celtic PLC - Glasgow-based football club - Reports results for the year ended June 30. Revenue falls 23% on-year to £111.0 million from £143.6 million, "primarily as a result of dropping into the Europa League as compared to the Champions League in the prior year." Chair Brian Wilson adds: "As well as directly impacting [Union of European Football Associations] distributions, this also had a knock-on effect on other parts of the club including ticketing income and retail." Pretax loss is £6.6 million, flipping from a £45.7 million profit. Operating expenses, including labour, increased 4.3% to £122.1 million from £117.1 million. Gains on sales of player registrations total £16.0 million, down from £31.5 million. Cash at year end totals £66.4 million from £77.3 million one year prior. "Season 2025/26 was more turbulent than anyone would have wished for, though ultimately it ended with one of the most dramatic title wins in our history as we secured the SPFL Premiership in the final moments of play before adding the Scottish Cup to complete a double a week later," Wilson says.
----------
Copyright 2026 Alliance News Ltd. All Rights Reserved.